These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 21947761)

  • 1. Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms.
    Fernandez-Fernandez A; Manchanda R; McGoron AJ
    Appl Biochem Biotechnol; 2011 Dec; 165(7-8):1628-51. PubMed ID: 21947761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanosensors for early cancer detection and for therapeutic drug monitoring.
    Salvati E; Stellacci F; Krol S
    Nanomedicine (Lond); 2015; 10(23):3495-512. PubMed ID: 26606949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles Design for Theranostic Approach in Cancer Disease.
    Carrese B; Sanità G; Lamberti A
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in refunctionalization of erythrocyte-based nanomedicine for enhancing cancer-targeted drug delivery.
    Sun D; Chen J; Wang Y; Ji H; Peng R; Jin L; Wu W
    Theranostics; 2019; 9(23):6885-6900. PubMed ID: 31660075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Advancing Role of Nanocomposites in Cancer Diagnosis and Treatment.
    Andoh V; Ocansey DKW; Naveed H; Wang N; Chen L; Chen K; Mao F
    Int J Nanomedicine; 2024; 19():6099-6126. PubMed ID: 38911500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology platforms and physiological challenges for cancer therapeutics.
    Kim KY
    Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interlocked systems in nanomedicine.
    Ornelas-Megiatto C; Becher TB; Megiatto JD
    Curr Top Med Chem; 2015; 15(13):1236-56. PubMed ID: 25858133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Versatile carbon nanoplatforms for cancer treatment and diagnosis: strategies, applications and future perspectives.
    Tang L; Li J; Pan T; Yin Y; Mei Y; Xiao Q; Wang R; Yan Z; Wang W
    Theranostics; 2022; 12(5):2290-2321. PubMed ID: 35265211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The upcoming field of theranostic nanomedicine: an overview.
    Prabhu P; Patravale V
    J Biomed Nanotechnol; 2012 Dec; 8(6):859-82. PubMed ID: 23029995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics.
    Tan YY; Yap PK; Xin Lim GL; Mehta M; Chan Y; Ng SW; Kapoor DN; Negi P; Anand K; Singh SK; Jha NK; Lim LC; Madheswaran T; Satija S; Gupta G; Dua K; Chellappan DK
    Chem Biol Interact; 2020 Sep; 329():109221. PubMed ID: 32768398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional nanomedicine platforms for cancer therapy.
    Zhang H
    J Nanosci Nanotechnol; 2012 May; 12(5):4012-8. PubMed ID: 22852341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicine for cancer diagnosis and therapy: advancement, success and structure-activity relationship.
    Bhise K; Sau S; Alsaab H; Kashaw SK; Tekade RK; Iyer AK
    Ther Deliv; 2017 Nov; 8(11):1003-1018. PubMed ID: 29061101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid Nanoplatforms Comprising Organic Nanocompartments Encapsulating Inorganic Nanoparticles for Enhanced Drug Delivery and Bioimaging Applications.
    Yanar F; Carugo D; Zhang X
    Molecules; 2023 Jul; 28(15):. PubMed ID: 37570666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
    Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
    Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of multifunctional nanocarriers for delivery of anti-cancer therapy.
    Mehra NK; Jain K; Jain NK
    Curr Pharm Des; 2015; 21(42):6157-64. PubMed ID: 26503145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions.
    Raj R; Mongia P; Kumar Sahu S; Ram A
    Curr Drug Targets; 2016; 17(2):206-28. PubMed ID: 26201484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered Polymer-Based Nanomaterials for Diagnostic, Therapeutic and Theranostic Applications.
    Parisi OI; Scrivano L; Sinicropi MS; Picci N; Puoci F
    Mini Rev Med Chem; 2016; 16(9):754-61. PubMed ID: 26156541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect.
    Sajja HK; East MP; Mao H; Wang YA; Nie S; Yang L
    Curr Drug Discov Technol; 2009 Mar; 6(1):43-51. PubMed ID: 19275541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.